Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation.

IF 0.3 Q4 OPHTHALMOLOGY
Ugyen Zangmo, Sushma Jayanna, Mahesh P Shanmugam
{"title":"Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation.","authors":"Ugyen Zangmo, Sushma Jayanna, Mahesh P Shanmugam","doi":"10.3126/nepjoph.v15i2.55033","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Aetiology for non-closure of full-thickness macular hole (FTMH) becomes crucial in determining the method of effective mode of intervention. Association of epiretinal proliferation (ERP) along with full-thickness macular hole (FTMH) have shown poorer anatomic and visual outcomes after surgical intervention. Various surgical techniques have been described in literature for treatment of persistent MH.</p><p><strong>Case: </strong>We report a A 60-year-old female patient with FTMH secondary to branched retinal vein occlusion (BRVO) initially associated with ERP.</p><p><strong>Observations: </strong>She was successfully managed by treating with combination of intravitreal injection of off label bevacizumab (Avastin) (1.25 mg/0.05 ml) and pure gas of SF6 (1 cc) under topical anaesthesia after an initial surgical intervention.</p><p><strong>Conclusion: </strong>Presence of ERP in retinal vein occlusion cases needs closer and frequent follow up. IVB can be used as an adjunct in treating secondary MH.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"15 30","pages":"97-101"},"PeriodicalIF":0.3000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nepalese Journal of Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/nepjoph.v15i2.55033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Aetiology for non-closure of full-thickness macular hole (FTMH) becomes crucial in determining the method of effective mode of intervention. Association of epiretinal proliferation (ERP) along with full-thickness macular hole (FTMH) have shown poorer anatomic and visual outcomes after surgical intervention. Various surgical techniques have been described in literature for treatment of persistent MH.

Case: We report a A 60-year-old female patient with FTMH secondary to branched retinal vein occlusion (BRVO) initially associated with ERP.

Observations: She was successfully managed by treating with combination of intravitreal injection of off label bevacizumab (Avastin) (1.25 mg/0.05 ml) and pure gas of SF6 (1 cc) under topical anaesthesia after an initial surgical intervention.

Conclusion: Presence of ERP in retinal vein occlusion cases needs closer and frequent follow up. IVB can be used as an adjunct in treating secondary MH.

玻璃体内贝伐单抗治疗伴有视网膜外增殖的持续性继发性黄斑孔。
背景:全厚黄斑孔(FTMH)不闭合的病因对于确定有效的干预方法至关重要。伴有视网膜上皮增生(ERP)的全厚性黄斑孔(FTMH)在手术干预后的解剖和视觉效果较差。文献中描述了多种治疗顽固性黄斑裂孔的手术方法:我们报告了一名 60 岁女性患者的病例,她因支行视网膜静脉闭塞(BRVO)继发 FTMH,最初与 ERP 相关:我们报告了一名 60 岁女性 FTMH 患者,她因视网膜分支静脉闭塞(BRVO)最初伴有 ERP,接受了非标签贝伐单抗(安维汀)(1.25 毫克/0.05 毫升)和 SF6 纯气体(1 毫升)的联合静脉注射治疗:结论:视网膜静脉闭塞病例中出现的ERP需要更密切和频繁的随访。IVB可作为治疗继发性MH的辅助手段。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
27
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信